How should I manage a genital outbreak when the PCR is negative for herpes simplex virus type 1 and type 2 but serum HSV‑2 IgG antibodies are positive?

Management of PCR-Negative Genital Outbreak with Positive HSV-2 Serology

Treat this as a recurrent HSV-2 outbreak and initiate episodic antiviral therapy immediately, despite the negative PCR result. The positive HSV-2 IgG serology confirms established infection, and PCR can be falsely negative in 12-30% of recurrent genital herpes cases 1.

Understanding the Clinical Scenario

This presentation represents a recurrent HSV-2 outbreak with false-negative PCR testing. The positive HSV-2 antibodies indicate you have established infection, meaning this is not a first episode. PCR negativity occurs commonly in recurrent episodes due to:

• Timing of specimen collection (lesions may be healing or in late stages)
• Inadequate sampling technique (insufficient viral material obtained)
• Lower viral loads in recurrent episodes compared to primary infection
• Technical limitations of the assay itself

Research confirms that commercial type-specific HSV-2 antibody tests can miss 12-30% of patients with PCR-confirmed recurrent genital herpes 1, but the reverse is also true—PCR can miss clinically active disease when serology is positive.

Immediate Treatment Approach

Episodic Therapy Regimens (Choose One):

• Acyclovir 400 mg orally three times daily for 5 days, OR
• Acyclovir 800 mg orally twice daily for 5 days, OR
• Valacyclovir 500 mg orally twice daily for 5 days, OR
• Famciclovir 125 mg orally twice daily for 5 days 2

Start treatment immediately—ideally within 24 hours of symptom onset or during prodrome for maximum benefit 2. Waiting for confirmatory testing wastes the narrow therapeutic window when antivirals are most effective.

Consider Suppressive Therapy

After treating this acute episode, discuss daily suppressive therapy with your healthcare provider, particularly if:

• You experience ≥6 recurrences per year (suppressive therapy reduces recurrence frequency by ≥75%) 2
• You want to reduce transmission risk to sexual partners (suppressive therapy decreases but does not eliminate asymptomatic viral shedding) 2
• Recurrences significantly impact your quality of life or psychological well-being

Suppressive Therapy Regimens (Choose One):

• Acyclovir 400 mg orally twice daily, OR
• Valacyclovir 500 mg orally once daily (less effective if ≥10 episodes/year), OR
• Valacyclovir 1000 mg orally once daily, OR
• Famciclovir 250 mg orally twice daily 2

Critical Counseling Points

Transmission Risk Management:

• Abstain from sexual activity when lesions or prodromal symptoms are present 2
• Use condoms consistently with all sexual partners, though they don't provide complete protection 2
• Asymptomatic viral shedding occurs frequently with HSV-2 (more than HSV-1), especially in the first 12 months after infection—transmission can occur even without visible lesions 2
• Inform sexual partners of your HSV-2 status 2

For Women of Childbearing Age:

Inform all healthcare providers during pregnancy about your HSV-2 infection, as neonatal transmission risk exists, particularly if you acquire new infection or have an outbreak near delivery 2.

Common Pitfalls to Avoid

1. Don't dismiss symptoms because PCR is negative—clinical diagnosis combined with positive serology is sufficient for treatment in established infection
2. Don't delay treatment waiting for repeat testing—the therapeutic window is narrow (within 24 hours of symptom onset)
3. Don't assume you're not infectious between outbreaks—asymptomatic shedding is common with HSV-2 2
4. Don't stop suppressive therapy without medical discussion after starting it—reassess annually to determine ongoing need 2

When to Seek Urgent Care

Seek immediate medical attention if you develop:

• Severe or disseminated disease (widespread lesions, systemic symptoms)
• Neurological symptoms (severe headache, confusion, neck stiffness suggesting meningitis/encephalitis)
• Lesions that don't respond to standard antiviral therapy within 7-10 days (consider acyclovir resistance) 2

For suspected acyclovir resistance, IV foscarnet is the treatment of choice, requiring specialist consultation 2, 3.